Jacobs Levy Equity Management
CDNA icon

Jacobs Levy Equity Management’s CareDx CDNA Stock Holding History

Jacobs Levy Equity Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.4M Buy
995,669
+131,201
+15% +$2.86M 0.1% 179
2026
Q1 		$15M Sell
864,468
-84,089
-9% -$1.59M 0.06% 248
2025
Q4 		$17.9M Buy
948,557
+244,477
+35% +$4.1M 0.07% 225
2025
Q3 		$10.2M Sell
704,080
-388,321
-36% -$5.54M 0.04% 295
2025
Q2 		$21.3M Sell
1,092,401
-47,619
-4% -$846K 0.08% 204
2025
Q1 		$20.2M Sell
1,140,020
-103,560
-8% -$2.23M 0.08% 222
2024
Q4 		$26.6M Buy
1,243,580
+428,864
+53% +$10.4M 0.09% 192
2024
Q3 		$25.4M Sell
814,716
-363,324
-31% -$9.04M 0.1% 196
2024
Q2 		$18.3M Buy
1,178,040
+27,068
+2% +$327K 0.08% 238
2024
Q1 		$12.2M Buy
1,150,972
+92,363
+9% +$924K 0.05% 270
2023
Q4 		$12.7M Sell
1,058,609
-65,505
-6% -$537K 0.06% 274
2023
Q3 		$7.87M Buy
1,124,114
+432,090
+62% +$3.99M 0.05% 293
2023
Q2 		$5.88M Buy
+692,024
New +$5.77M 0.03% 363

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management's CDNA Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its CareDx (CDNA) stake by 15% in Q2 2026, buying an estimated $2.86M and bringing the position to 995,669 shares worth $28.4M. The position accounts for 0.1% of the portfolio, ranked #179.

Jacobs Levy Equity Management first reported a position in CDNA in Q2 2023 and has held it in 13 quarters since. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Jacobs Levy Equity Management held 995,669 shares of CareDx worth $28.4M as of Q2 2026.
  • Jacobs Levy Equity Management bought 131,201 CareDx shares in Q2 2026, an estimated $2.86M.
  • CareDx made up 0.1% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #179 holding.
  • Jacobs Levy Equity Management first reported a position in CareDx in Q2 2023 and has held it in 13 quarters since.
  • 228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.